EMILY FERGUSON: Open Payments
NPI 1194210575 · JASPER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 75 payments from 14 companies in 2025. Trend: 2023 $1,182 · 2024 $1,183 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $184 |
| ABBVIE INC. | 16 | $183 |
| Otsuka America Pharmaceutical, Inc. | 14 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Abbott Laboratories | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
Products named: NURTEC ODT, REXULTI, QULIPTA, CAPLYTA, TRINTELLIX, Auvelity, VRAYLAR, UBRELVY.
Industry payments across IN — which companies pay providers there.
